DRBREASTCANCER.COM

Scientists from Australia’s South Australia (SA) state have discovered how an obscure protein can accelerate the development and growth of breast cancer. In...

A team of researchers led by Worcester Polytechnic Institute (WPI) Provost Wole Soboyejo has identified targeted drugs that reduced the sizes of hard-to-treat...

HCG Cancer Hospital has enabled virtual consultation facility across its 24 hospitals in the country to continue the OPD operations during the lockdown Early...

Breast cancer survivor Karen Davis has welcomed the ‘brilliant’ results of a radiotherapy trial which will transform care for patients. She was...

Although significant progress has been made in breast cancer care, challenges and opportunities remain in cancer survivorship. “There are a growing number...

Two women with incurable breast cancer whose lives were “flipped upside down” by the diagnosis have set up a group to offer hope to others. ...

Although estrogen alone appeared to decrease the incidence of breast cancer in the long term in postmenopausal women who had undergone hysterectomy,...

On March 8, 2019, the US Food and Drug Administration (FDA) approved the PD-L1 inhibitor atezolizumab for first-line treatment of metastatic triple-negative breast...

Oral paclitaxel with encequidar appeared to be have the same if not better clinical benefit than intravenous paclitaxel for patients with metastatic breast...

Madan,( Name changed ) 53, had a lump in his right breast for more than six years. But he didn’t bother much about it. “When I first noticed it six-seven...